Amanda Law
Concepts (319)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 33 | 2019 | 443 | 6.570 |
Why?
| | Neuregulin-1 | 17 | 2020 | 49 | 3.250 |
Why?
| | Prefrontal Cortex | 13 | 2020 | 331 | 2.560 |
Why?
| | Neuregulins | 5 | 2020 | 7 | 2.290 |
Why?
| | Hippocampus | 17 | 2020 | 966 | 1.730 |
Why?
| | ErbB Receptors | 8 | 2020 | 632 | 1.660 |
Why?
| | Nerve Tissue Proteins | 10 | 2015 | 590 | 1.550 |
Why?
| | Alternative Splicing | 6 | 2020 | 247 | 1.350 |
Why?
| | Brain | 15 | 2021 | 2934 | 1.320 |
Why?
| | Proto-Oncogene Proteins c-akt | 5 | 2020 | 435 | 1.270 |
Why?
| | Choline | 9 | 2022 | 136 | 1.140 |
Why?
| | Bipolar Disorder | 5 | 2016 | 278 | 1.080 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2020 | 452 | 1.030 |
Why?
| | Behavior, Animal | 4 | 2020 | 521 | 0.960 |
Why?
| | Protein Isoforms | 10 | 2018 | 396 | 0.940 |
Why?
| | Gene Expression Regulation, Developmental | 7 | 2020 | 906 | 0.900 |
Why?
| | Prenatal Exposure Delayed Effects | 7 | 2021 | 641 | 0.890 |
Why?
| | Cell Adhesion Molecules, Neuronal | 3 | 2015 | 42 | 0.860 |
Why?
| | Genetic Predisposition to Disease | 10 | 2019 | 2350 | 0.840 |
Why?
| | Gene Expression | 9 | 2018 | 1476 | 0.810 |
Why?
| | Antipsychotic Agents | 6 | 2016 | 214 | 0.800 |
Why?
| | MicroRNAs | 2 | 2019 | 689 | 0.760 |
Why?
| | Receptor, ErbB-4 | 9 | 2020 | 18 | 0.750 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2020 | 380 | 0.740 |
Why?
| | RNA, Messenger | 16 | 2020 | 2815 | 0.700 |
Why?
| | Fetus | 8 | 2021 | 800 | 0.670 |
Why?
| | Polymorphism, Single Nucleotide | 9 | 2014 | 2137 | 0.670 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 2 | 2019 | 108 | 0.670 |
Why?
| | Brain Chemistry | 4 | 2009 | 116 | 0.660 |
Why?
| | Maternal Deprivation | 3 | 2010 | 16 | 0.650 |
Why?
| | Aging | 4 | 2020 | 1938 | 0.620 |
Why?
| | C-Reactive Protein | 4 | 2022 | 420 | 0.620 |
Why?
| | Fetal Development | 7 | 2021 | 295 | 0.610 |
Why?
| | Sensory Gating | 2 | 2019 | 44 | 0.610 |
Why?
| | Minisatellite Repeats | 1 | 2019 | 36 | 0.600 |
Why?
| | Signal Transduction | 9 | 2018 | 5185 | 0.560 |
Why?
| | Genotype | 8 | 2016 | 1847 | 0.550 |
Why?
| | Cloning, Molecular | 2 | 2010 | 535 | 0.540 |
Why?
| | Gene Expression Regulation | 5 | 2019 | 2591 | 0.520 |
Why?
| | Interleukin-1beta | 1 | 2019 | 390 | 0.520 |
Why?
| | Glutamic Acid | 2 | 2018 | 254 | 0.510 |
Why?
| | gamma-Aminobutyric Acid | 3 | 2018 | 194 | 0.500 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 3 | 2003 | 229 | 0.490 |
Why?
| | Cerebral Cortex | 3 | 2011 | 470 | 0.490 |
Why?
| | Neurophysiology | 1 | 2016 | 13 | 0.480 |
Why?
| | Multiprotein Complexes | 1 | 2017 | 171 | 0.460 |
Why?
| | Memory Disorders | 1 | 2017 | 196 | 0.460 |
Why?
| | Microfilament Proteins | 3 | 2008 | 136 | 0.460 |
Why?
| | Mood Disorders | 2 | 2008 | 140 | 0.450 |
Why?
| | Microtubule-Associated Proteins | 3 | 2008 | 195 | 0.450 |
Why?
| | Neocortex | 1 | 2015 | 49 | 0.430 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2019 | 1207 | 0.430 |
Why?
| | Psychomotor Performance | 2 | 2014 | 328 | 0.420 |
Why?
| | Epidermal Growth Factor | 1 | 2014 | 161 | 0.410 |
Why?
| | Gestational Age | 5 | 2022 | 980 | 0.400 |
Why?
| | Adult | 29 | 2022 | 40489 | 0.380 |
Why?
| | Neurogenesis | 1 | 2014 | 157 | 0.370 |
Why?
| | Alleles | 3 | 2011 | 886 | 0.350 |
Why?
| | Promoter Regions, Genetic | 4 | 2019 | 1246 | 0.350 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2021 | 431 | 0.340 |
Why?
| | Quinazolines | 1 | 2012 | 266 | 0.320 |
Why?
| | Heterozygote | 1 | 2011 | 313 | 0.320 |
Why?
| | Female | 36 | 2022 | 78304 | 0.320 |
Why?
| | Inflammation | 3 | 2021 | 2870 | 0.310 |
Why?
| | Infant Behavior | 2 | 2020 | 27 | 0.310 |
Why?
| | Humans | 49 | 2022 | 144671 | 0.310 |
Why?
| | Male | 32 | 2022 | 72431 | 0.300 |
Why?
| | Adenine | 1 | 2012 | 337 | 0.300 |
Why?
| | Pregnancy | 13 | 2022 | 7122 | 0.300 |
Why?
| | Phenotype | 2 | 2014 | 3147 | 0.290 |
Why?
| | Pyramidal Cells | 3 | 2004 | 80 | 0.290 |
Why?
| | Infant, Newborn | 11 | 2022 | 6399 | 0.280 |
Why?
| | Paternal Deprivation | 1 | 2008 | 4 | 0.280 |
Why?
| | Peptides | 1 | 2014 | 989 | 0.280 |
Why?
| | Gyrus Cinguli | 1 | 2008 | 96 | 0.280 |
Why?
| | Genome-Wide Association Study | 5 | 2019 | 1374 | 0.270 |
Why?
| | Case-Control Studies | 7 | 2019 | 3603 | 0.260 |
Why?
| | Animals | 17 | 2021 | 37948 | 0.260 |
Why?
| | Amygdala | 1 | 2008 | 198 | 0.260 |
Why?
| | Memory, Short-Term | 3 | 2018 | 271 | 0.250 |
Why?
| | Cyclophilins | 2 | 2004 | 40 | 0.250 |
Why?
| | Young Adult | 11 | 2022 | 14122 | 0.250 |
Why?
| | Blotting, Western | 3 | 2016 | 1161 | 0.250 |
Why?
| | Disease Models, Animal | 3 | 2016 | 4539 | 0.240 |
Why?
| | Middle Aged | 18 | 2019 | 35971 | 0.240 |
Why?
| | Mice | 8 | 2020 | 18261 | 0.240 |
Why?
| | Neuronal Plasticity | 2 | 2008 | 306 | 0.240 |
Why?
| | Neurobiology | 1 | 2006 | 14 | 0.240 |
Why?
| | Infant | 10 | 2021 | 10023 | 0.220 |
Why?
| | Psychotic Disorders | 2 | 2021 | 185 | 0.220 |
Why?
| | Pregnancy Complications | 2 | 2021 | 586 | 0.220 |
Why?
| | Neural Cell Adhesion Molecules | 2 | 2015 | 38 | 0.210 |
Why?
| | Cohort Studies | 8 | 2016 | 5957 | 0.210 |
Why?
| | Protein Structure, Tertiary | 1 | 2006 | 849 | 0.210 |
Why?
| | Neurites | 1 | 2004 | 50 | 0.200 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 973 | 0.200 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 2003 | 50 | 0.200 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2016 | 339 | 0.200 |
Why?
| | Adolescent | 11 | 2019 | 22409 | 0.200 |
Why?
| | Dendrites | 1 | 2004 | 104 | 0.200 |
Why?
| | Hydrocortisone | 2 | 2020 | 297 | 0.200 |
Why?
| | Calcium-Binding Proteins | 2 | 2015 | 222 | 0.190 |
Why?
| | Depression | 3 | 2021 | 1561 | 0.190 |
Why?
| | Neurofilament Proteins | 1 | 2003 | 79 | 0.190 |
Why?
| | Memory | 2 | 2016 | 296 | 0.190 |
Why?
| | Folic Acid | 2 | 2021 | 198 | 0.190 |
Why?
| | Synapses | 3 | 2004 | 437 | 0.180 |
Why?
| | Infant, Small for Gestational Age | 1 | 2022 | 111 | 0.180 |
Why?
| | Heart Rate, Fetal | 1 | 2021 | 31 | 0.170 |
Why?
| | Child Development | 3 | 2021 | 482 | 0.170 |
Why?
| | Risk | 2 | 2014 | 911 | 0.170 |
Why?
| | Aged | 10 | 2019 | 25955 | 0.170 |
Why?
| | In Situ Hybridization | 4 | 2010 | 318 | 0.170 |
Why?
| | Up-Regulation | 3 | 2019 | 848 | 0.170 |
Why?
| | Molecular Sequence Data | 3 | 2010 | 2909 | 0.160 |
Why?
| | Callithrix | 3 | 2010 | 10 | 0.160 |
Why?
| | Down-Regulation | 2 | 2007 | 616 | 0.160 |
Why?
| | Mothers | 3 | 2021 | 765 | 0.160 |
Why?
| | Child | 11 | 2021 | 22600 | 0.160 |
Why?
| | Child, Preschool | 9 | 2021 | 11790 | 0.160 |
Why?
| | Receptor, ErbB-3 | 1 | 2020 | 48 | 0.160 |
Why?
| | Nerve Growth Factors | 1 | 2020 | 78 | 0.150 |
Why?
| | 5' Untranslated Regions | 1 | 2019 | 59 | 0.150 |
Why?
| | Animals, Newborn | 2 | 2014 | 890 | 0.150 |
Why?
| | HEK293 Cells | 2 | 2019 | 743 | 0.150 |
Why?
| | Organ Specificity | 1 | 2019 | 311 | 0.140 |
Why?
| | Haplotypes | 4 | 2013 | 495 | 0.140 |
Why?
| | Hallucinogens | 1 | 2021 | 109 | 0.140 |
Why?
| | Risk Factors | 6 | 2019 | 10796 | 0.140 |
Why?
| | Analysis of Variance | 3 | 2012 | 1301 | 0.140 |
Why?
| | Aged, 80 and over | 4 | 2016 | 8284 | 0.140 |
Why?
| | Nutritional Status | 1 | 2021 | 351 | 0.140 |
Why?
| | Adrenal Cortex Hormones | 1 | 2021 | 480 | 0.140 |
Why?
| | Neurons | 3 | 2019 | 1639 | 0.130 |
Why?
| | RNA, Long Noncoding | 1 | 2020 | 172 | 0.130 |
Why?
| | Mice, Transgenic | 4 | 2018 | 2184 | 0.130 |
Why?
| | Psychiatric Status Rating Scales | 3 | 2014 | 539 | 0.130 |
Why?
| | Age of Onset | 1 | 2019 | 551 | 0.130 |
Why?
| | Exons | 2 | 2010 | 362 | 0.130 |
Why?
| | Cell Lineage | 1 | 2019 | 376 | 0.130 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 2 | 2015 | 94 | 0.130 |
Why?
| | Maternal Exposure | 1 | 2019 | 185 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
| | Solute Carrier Family 12, Member 2 | 2 | 2014 | 7 | 0.130 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 1 | 2017 | 62 | 0.130 |
Why?
| | Genetic Markers | 2 | 2010 | 332 | 0.130 |
Why?
| | Autopsy | 2 | 2014 | 94 | 0.120 |
Why?
| | Reflex, Startle | 2 | 2014 | 75 | 0.120 |
Why?
| | Placenta | 2 | 2021 | 781 | 0.120 |
Why?
| | Locomotion | 1 | 2017 | 102 | 0.120 |
Why?
| | Conditioning, Classical | 1 | 2017 | 119 | 0.120 |
Why?
| | Immunohistochemistry | 3 | 2004 | 1705 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 3 | 2012 | 2521 | 0.110 |
Why?
| | Phosphatidylcholines | 1 | 2015 | 130 | 0.110 |
Why?
| | Tissue Distribution | 2 | 2006 | 335 | 0.110 |
Why?
| | Genotyping Techniques | 1 | 2014 | 70 | 0.100 |
Why?
| | Polymorphism, Genetic | 1 | 2016 | 613 | 0.100 |
Why?
| | Cannabis | 1 | 2021 | 509 | 0.100 |
Why?
| | Fear | 1 | 2017 | 366 | 0.100 |
Why?
| | Catechol O-Methyltransferase | 1 | 2013 | 20 | 0.100 |
Why?
| | Child Behavior | 1 | 2015 | 236 | 0.100 |
Why?
| | DiGeorge Syndrome | 1 | 2013 | 34 | 0.100 |
Why?
| | Blood-Brain Barrier | 1 | 2014 | 155 | 0.100 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1468 | 0.090 |
Why?
| | Photic Stimulation | 1 | 2014 | 264 | 0.090 |
Why?
| | Pharmacogenetics | 1 | 2014 | 172 | 0.090 |
Why?
| | Double-Blind Method | 2 | 2015 | 2033 | 0.090 |
Why?
| | Amphetamine | 1 | 2012 | 38 | 0.090 |
Why?
| | Dietary Supplements | 3 | 2021 | 575 | 0.090 |
Why?
| | Cell Line, Transformed | 1 | 2012 | 138 | 0.090 |
Why?
| | Mental Disorders | 1 | 2021 | 1154 | 0.090 |
Why?
| | Rats | 3 | 2012 | 5570 | 0.090 |
Why?
| | Cross-Over Studies | 1 | 2014 | 605 | 0.090 |
Why?
| | Cerebellum | 2 | 2004 | 224 | 0.090 |
Why?
| | Biological Clocks | 1 | 2011 | 48 | 0.080 |
Why?
| | Neuropsychiatry | 1 | 2011 | 17 | 0.080 |
Why?
| | Molecular Structure | 1 | 2012 | 495 | 0.080 |
Why?
| | Synaptophysin | 2 | 2008 | 15 | 0.080 |
Why?
| | Drug Discovery | 1 | 2011 | 153 | 0.080 |
Why?
| | Mice, Inbred C57BL | 3 | 2018 | 5967 | 0.080 |
Why?
| | Genetic Association Studies | 1 | 2012 | 369 | 0.080 |
Why?
| | Epistasis, Genetic | 1 | 2010 | 65 | 0.080 |
Why?
| | Receptors, Mineralocorticoid | 1 | 2010 | 11 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2019 | 0.080 |
Why?
| | Adenosine | 1 | 2011 | 255 | 0.080 |
Why?
| | Motor Activity | 1 | 2014 | 723 | 0.070 |
Why?
| | Family Health | 1 | 2010 | 191 | 0.070 |
Why?
| | Long-Term Potentiation | 1 | 2011 | 199 | 0.070 |
Why?
| | Social Isolation | 1 | 2010 | 73 | 0.070 |
Why?
| | Schizophrenic Psychology | 1 | 2009 | 97 | 0.070 |
Why?
| | Gene Frequency | 1 | 2010 | 481 | 0.070 |
Why?
| | Oxygen | 2 | 2014 | 984 | 0.070 |
Why?
| | Family | 1 | 2014 | 685 | 0.070 |
Why?
| | Tritium | 1 | 2008 | 68 | 0.070 |
Why?
| | Receptors, Serotonin | 1 | 2008 | 34 | 0.070 |
Why?
| | Vesicular Glutamate Transport Protein 1 | 1 | 2008 | 3 | 0.070 |
Why?
| | GAP-43 Protein | 1 | 2008 | 6 | 0.070 |
Why?
| | Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2008 | 10 | 0.070 |
Why?
| | Receptors, Glucocorticoid | 1 | 2010 | 130 | 0.070 |
Why?
| | Receptor, Serotonin, 5-HT1A | 1 | 2008 | 36 | 0.070 |
Why?
| | Flow Cytometry | 1 | 2012 | 1154 | 0.070 |
Why?
| | Prenatal Care | 2 | 2021 | 306 | 0.070 |
Why?
| | Action Potentials | 1 | 2011 | 502 | 0.070 |
Why?
| | Genetic Variation | 3 | 2011 | 985 | 0.070 |
Why?
| | Phosphorylation | 1 | 2012 | 1704 | 0.070 |
Why?
| | Vitamin D | 2 | 2021 | 400 | 0.070 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2008 | 151 | 0.060 |
Why?
| | Gene Components | 1 | 2006 | 6 | 0.060 |
Why?
| | Base Sequence | 1 | 2010 | 2177 | 0.060 |
Why?
| | B-Lymphocytes | 1 | 2012 | 875 | 0.060 |
Why?
| | Amino Acid Sequence | 1 | 2010 | 2136 | 0.060 |
Why?
| | Logistic Models | 3 | 2022 | 2114 | 0.060 |
Why?
| | Piperazines | 1 | 2008 | 378 | 0.060 |
Why?
| | Synaptic Transmission | 1 | 2008 | 292 | 0.060 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2010 | 779 | 0.060 |
Why?
| | Reward | 1 | 2008 | 245 | 0.060 |
Why?
| | Membrane Proteins | 2 | 2010 | 1159 | 0.060 |
Why?
| | Receptors, Nicotinic | 1 | 2007 | 328 | 0.050 |
Why?
| | Autoradiography | 1 | 2004 | 66 | 0.050 |
Why?
| | Histocytochemistry | 1 | 2004 | 78 | 0.050 |
Why?
| | Chlorpromazine | 1 | 2004 | 5 | 0.050 |
Why?
| | Clozapine | 1 | 2004 | 20 | 0.050 |
Why?
| | Pyridines | 1 | 2008 | 603 | 0.050 |
Why?
| | Risperidone | 1 | 2004 | 29 | 0.050 |
Why?
| | Functional Laterality | 2 | 2003 | 241 | 0.050 |
Why?
| | Haloperidol | 1 | 2004 | 33 | 0.050 |
Why?
| | Amino Acid Transport System X-AG | 1 | 2003 | 5 | 0.050 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2004 | 47 | 0.050 |
Why?
| | Receptors, Glutamate | 1 | 2003 | 26 | 0.050 |
Why?
| | Oligonucleotide Probes | 1 | 2003 | 48 | 0.050 |
Why?
| | Receptors, Growth Factor | 1 | 2003 | 53 | 0.050 |
Why?
| | Semaphorin-3A | 1 | 2003 | 2 | 0.050 |
Why?
| | Brain Stem | 1 | 2004 | 97 | 0.050 |
Why?
| | Purkinje Cells | 1 | 2004 | 65 | 0.050 |
Why?
| | Cell Count | 1 | 2003 | 320 | 0.050 |
Why?
| | Presynaptic Terminals | 1 | 2004 | 89 | 0.050 |
Why?
| | Postmortem Changes | 2 | 2014 | 17 | 0.050 |
Why?
| | Fluorescent Antibody Technique | 1 | 2003 | 364 | 0.050 |
Why?
| | Benzodiazepines | 1 | 2004 | 168 | 0.050 |
Why?
| | Binding Sites | 1 | 2006 | 1307 | 0.050 |
Why?
| | Protein Binding | 1 | 2008 | 2243 | 0.050 |
Why?
| | Absorptiometry, Photon | 1 | 2003 | 276 | 0.050 |
Why?
| | Pandemics | 2 | 2021 | 1700 | 0.040 |
Why?
| | Wechsler Scales | 1 | 2021 | 59 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 1 | 2021 | 114 | 0.040 |
Why?
| | Social Problems | 1 | 2021 | 12 | 0.040 |
Why?
| | Vitamin A | 1 | 2021 | 59 | 0.040 |
Why?
| | Nutritional Requirements | 1 | 2021 | 77 | 0.040 |
Why?
| | Intelligence | 1 | 2021 | 110 | 0.040 |
Why?
| | Nerve Net | 1 | 2003 | 284 | 0.040 |
Why?
| | Micronutrients | 1 | 2021 | 101 | 0.040 |
Why?
| | Nootropic Agents | 1 | 2020 | 30 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2021 | 141 | 0.040 |
Why?
| | Vitamins | 1 | 2021 | 176 | 0.040 |
Why?
| | Object Attachment | 1 | 2020 | 48 | 0.040 |
Why?
| | Pituitary-Adrenal System | 1 | 2020 | 163 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2003 | 1103 | 0.040 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2020 | 196 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2014 | 11735 | 0.040 |
Why?
| | Maternal Age | 1 | 2019 | 126 | 0.040 |
Why?
| | Reference Values | 2 | 2010 | 794 | 0.030 |
Why?
| | Developmental Disabilities | 1 | 2021 | 279 | 0.030 |
Why?
| | Transcription Factors | 1 | 2006 | 1726 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2010 | 3888 | 0.030 |
Why?
| | Stress, Psychological | 2 | 2020 | 1148 | 0.030 |
Why?
| | Encephalitis | 1 | 2018 | 142 | 0.030 |
Why?
| | Urinary Tract Infections | 1 | 2019 | 206 | 0.030 |
Why?
| | Attention | 1 | 2020 | 458 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1505 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2001 | 776 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 387 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 381 | 0.030 |
Why?
| | Respiratory Tract Infections | 1 | 2019 | 395 | 0.030 |
Why?
| | DNA, Recombinant | 1 | 2014 | 48 | 0.030 |
Why?
| | Valine | 1 | 2013 | 80 | 0.020 |
Why?
| | Chromosome Deletion | 1 | 2013 | 124 | 0.020 |
Why?
| | Methionine | 1 | 2013 | 162 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2013 | 524 | 0.020 |
Why?
| | Transcriptome | 1 | 2018 | 1036 | 0.020 |
Why?
| | Sodium-Potassium-Chloride Symporters | 1 | 2011 | 9 | 0.020 |
Why?
| | New York | 1 | 2011 | 127 | 0.020 |
Why?
| | Symporters | 1 | 2011 | 48 | 0.020 |
Why?
| | Epigenomics | 1 | 2011 | 112 | 0.020 |
Why?
| | Glutamate Decarboxylase | 1 | 2011 | 165 | 0.020 |
Why?
| | Genetic Carrier Screening | 1 | 2010 | 32 | 0.020 |
Why?
| | Disks Large Homolog 4 Protein | 1 | 2010 | 18 | 0.020 |
Why?
| | Nitric Oxide Synthase Type I | 1 | 2010 | 30 | 0.020 |
Why?
| | Time | 1 | 2010 | 86 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2014 | 539 | 0.020 |
Why?
| | Movement Disorders | 1 | 2009 | 70 | 0.020 |
Why?
| | Tremor | 1 | 2009 | 98 | 0.020 |
Why?
| | Siblings | 1 | 2009 | 195 | 0.020 |
Why?
| | Neural Inhibition | 1 | 2009 | 178 | 0.020 |
Why?
| | Molecular Targeted Therapy | 1 | 2011 | 437 | 0.020 |
Why?
| | Control Groups | 1 | 2008 | 12 | 0.020 |
Why?
| | Research | 1 | 2011 | 431 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2010 | 426 | 0.020 |
Why?
| | Immunoblotting | 1 | 2008 | 293 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2010 | 454 | 0.020 |
Why?
| | Cytoplasm | 1 | 2008 | 257 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5870 | 0.020 |
Why?
| | Pedigree | 1 | 2008 | 515 | 0.020 |
Why?
| | Anxiety Disorders | 1 | 2009 | 370 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2007 | 1046 | 0.010 |
Why?
| | Artificial Intelligence | 1 | 2010 | 381 | 0.010 |
Why?
| | Research Design | 1 | 2011 | 1129 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2008 | 592 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2011 | 4110 | 0.010 |
Why?
| | Models, Biological | 1 | 2011 | 1811 | 0.010 |
Why?
| | Glutamates | 1 | 2003 | 66 | 0.010 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2003 | 45 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 4081 | 0.010 |
Why?
| | Algorithms | 1 | 2010 | 1844 | 0.010 |
Why?
| | Serine Endopeptidases | 1 | 2003 | 129 | 0.010 |
Why?
| | Extracellular Matrix Proteins | 1 | 2003 | 156 | 0.010 |
Why?
| | Axons | 1 | 2003 | 203 | 0.010 |
Why?
| | Smoking | 1 | 2007 | 1467 | 0.010 |
Why?
| | Disease Progression | 1 | 2003 | 2847 | 0.010 |
Why?
| | Biomarkers | 1 | 2003 | 4261 | 0.010 |
Why?
|
|
Law's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|